Home » Newsletters » BioWorld Science

BioWorld Science

June 5, 2002

View Archived Issues

New rapamycin analogues as potential immunosuppressants

Shionogi reports novel matrix metalloproteinase inhibitors and therapeutic applications thereof

Daiichi patents factor Xa-inhibitory amidines

Xanthine oxidase inhibitors claimed by Teijin for use in gout, etc.

Antitumor platinum complexes designed at AnorMED

CCR3 antagonists reportedly useful for allergic inflammatory diseases

Novel small molecule discovered by NeuroSearch and NsGene to exert neurotrophic-like effects

MDX-010 induces tumor reductions in phase I trials in metastatic melanoma and prostate cancer

Iseganan hydrochloride prevents oral mucositis in phase III trial

All patients with aggressive NHL respond to Onco TCS combination therapy

Pfizer establishes potential utility of small-molecule alpha4beta1 antagonists in asthma

Chronic DPP-IV inhibition with FE-999011 delays development of diabetes

Potential of phytoestrogens in the therapy of overactive bladder

Weekly administration of WX-G250 is safe and effective against renal cell carcinoma

Omalizumab is especially effective and well tolerated in severe asthma

New data on DC101 presented at the AUA meeting

J591 has antitumor effects in patients with advanced prostate cancer

Cellegy submits NDA for Tostrex in male hypogonadism

Heat-killed M. vaccae tested in mouse model of atopic asthma

Spiriva launched for COPD in The Netherlands and the Philippines

Dyax and Genzyme restructure DX-88 collaboration

Vyteris submits NDA for lidocaine patch

First U.S. phase I trial initiated for Aquavan

Patient dosing completed in phase II trial of C. jejuni vaccine

CPMP recommends approval of ARANESP for anemia in cancer patients

First phase III trial of indiplon-MR initiated in primary insomnia

Pooled analysis of clinical trial data for rupatadine in allergic rhinitis presented in Naples

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...